Cyclopropane

Cyclopropane

SCHEMBL2441865

C1CC1.O=C(O)Nc1noc2cccc(OCC(F)(F)F)c12

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 2/20 0.39
SGMS2 Q8NHU3 13/20 0.39
SGMS1 Q86VZ5 6/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.37
S1PR2 O95136 1/20 0.37
S1PR4 O95977 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
XBP1 P17861 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
PAX8 Q06710 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
S1PR3 Q99500 1/20 0.37
S1PR5 Q9H228 1/20 0.37
UGCG Q16739 1/20 0.36
LCLAT1 Q6UWP7 1/20 0.35
KIT P10721 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL2442882 1.00 KCNA5 (0.39) KCNA5SGMS2SGMS1SMN1; SMN2MEN1
SCHEMBL2442656 0.82 KCNA5 (0.40) KCNA5SGMS2SGMS1SMN1; SMN2MEN1
SCHEMBL3560647 0.81 KCNA5 (0.36) KCNA5SGMS2SGMS1SMN1; SMN2MEN1
SCHEMBL2439003 0.81 KDM4E (0.42) KCNA5SGMS2SGMS1MAPTKMT2A
SCHEMBL2438849 0.80 SMN1; SMN2 (0.45) KCNA5SMN1; SMN2MAPTKMT2AUGCG
SCHEMBL2441287 0.80 SMN1; SMN2 (0.43) SGMS2SGMS1SMN1; SMN2UGCGLCLAT1
SCHEMBL2437982 0.80 S1PR1 (0.49) KCNA5SGMS2SGMS1SMN1; SMN2MEN1
SCHEMBL2440639 0.79 SGMS2 (0.38) KCNA5SGMS2SGMS1MAPTLCLAT1
SCHEMBL3560643 0.79 SGMS2 (0.37) KCNA5SGMS2SGMS1SMN1; SMN2
Cyclopropane SCHEMBL2442932 0.79 SCN9A (0.37) SGMS2SGMS1KMT2ALCLAT1KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893589-B1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-09-14 EP claimed
EP-1893589-A1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS Grünenthal GmbH (DE) 2008-03-05 EP claimed
WO-2006131296-A1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS Grünenthal GmbH (DE) 2006-12-14 WO claimed
EP-1893589-B1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-09-14 EP disclosed